A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation

Control of a biventricular assist device (BiVAD) is more challenging than control of a left ventricular assist device due to the process interactions between control loops in a multi-input-multi-output system. Hence, a single centralized multi-objective model predictive controller (CMO-MPC) has been...

Full description

Saved in:
Bibliographic Details
Main Authors: Koh, V. C. A., Pauls, J. P., Wu, E. L., Stevens, M. C., Ho, Y. K., Lovell, N. H., Lim, E.
Format: Article
Published: Elsevier Sci Ltd 2020
Subjects:
Online Access:http://eprints.um.edu.my/36725/
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Malaya
id my.um.eprints.36725
record_format eprints
spelling my.um.eprints.367252024-11-05T08:21:35Z http://eprints.um.edu.my/36725/ A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation Koh, V. C. A. Pauls, J. P. Wu, E. L. Stevens, M. C. Ho, Y. K. Lovell, N. H. Lim, E. Q Science (General) Medical technology Control of a biventricular assist device (BiVAD) is more challenging than control of a left ventricular assist device due to the process interactions between control loops in a multi-input-multi-output system. Hence, a single centralized multi-objective model predictive controller (CMO-MPC) has been developed to control a BiVAD. The CMO-MPC aims to: 1) adapt pump flow rate according to the Frank-Starling mechanism, 2) avoid ventricular suction, and 3) avoid vascular congestion. The CMO-MPC was benchmarked against a constant-speed (CS) setting in exercise, postural change, and systemic vascular resistance change tests in a mock circulation loop. The CMO-MPC increased pump flow rate from 5.0 L/min to 7.6 L/min in the exercise scenario, which was higher than the pump flow rate in the CS setting (6.0 L/min). In the postural change test, right ventricular end diastolic pressure (RVEDP) decreased to a minimum at 0.1 mmHg and 2.0 mmHg in the CS setting and the CMO-MPC, respectively, indicating that the CMO-MPC could minimize the risk of ventricular suction (with higher minimum RVEDP than the CS setting) when there was a sudden decrease in venous return. In all tests, the CMO-MPC could adapt pump flow rate without resulting events of ventricular suction and vascular congestion. (C) 2020 Elsevier Ltd. All rights reserved. Elsevier Sci Ltd 2020-05 Article PeerReviewed Koh, V. C. A. and Pauls, J. P. and Wu, E. L. and Stevens, M. C. and Ho, Y. K. and Lovell, N. H. and Lim, E. (2020) A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation. Biomedical Signal Processing and Control, 59. ISSN 1746-8094, DOI https://doi.org/10.1016/j.bspc.2020.101914 <https://doi.org/10.1016/j.bspc.2020.101914>. 10.1016/j.bspc.2020.101914
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
topic Q Science (General)
Medical technology
spellingShingle Q Science (General)
Medical technology
Koh, V. C. A.
Pauls, J. P.
Wu, E. L.
Stevens, M. C.
Ho, Y. K.
Lovell, N. H.
Lim, E.
A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation
description Control of a biventricular assist device (BiVAD) is more challenging than control of a left ventricular assist device due to the process interactions between control loops in a multi-input-multi-output system. Hence, a single centralized multi-objective model predictive controller (CMO-MPC) has been developed to control a BiVAD. The CMO-MPC aims to: 1) adapt pump flow rate according to the Frank-Starling mechanism, 2) avoid ventricular suction, and 3) avoid vascular congestion. The CMO-MPC was benchmarked against a constant-speed (CS) setting in exercise, postural change, and systemic vascular resistance change tests in a mock circulation loop. The CMO-MPC increased pump flow rate from 5.0 L/min to 7.6 L/min in the exercise scenario, which was higher than the pump flow rate in the CS setting (6.0 L/min). In the postural change test, right ventricular end diastolic pressure (RVEDP) decreased to a minimum at 0.1 mmHg and 2.0 mmHg in the CS setting and the CMO-MPC, respectively, indicating that the CMO-MPC could minimize the risk of ventricular suction (with higher minimum RVEDP than the CS setting) when there was a sudden decrease in venous return. In all tests, the CMO-MPC could adapt pump flow rate without resulting events of ventricular suction and vascular congestion. (C) 2020 Elsevier Ltd. All rights reserved.
format Article
author Koh, V. C. A.
Pauls, J. P.
Wu, E. L.
Stevens, M. C.
Ho, Y. K.
Lovell, N. H.
Lim, E.
author_facet Koh, V. C. A.
Pauls, J. P.
Wu, E. L.
Stevens, M. C.
Ho, Y. K.
Lovell, N. H.
Lim, E.
author_sort Koh, V. C. A.
title A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation
title_short A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation
title_full A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation
title_fullStr A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation
title_full_unstemmed A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation
title_sort centralized multi-objective model predictive control for a biventricular assist device: an in vitro evaluation
publisher Elsevier Sci Ltd
publishDate 2020
url http://eprints.um.edu.my/36725/
_version_ 1814933263082323968